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Cytogenetic Analysis of Posterior Uveal Melanoma 
Rodney N. Wiltshire, Victor M. Elner, Thomas Dennis, 
Andrew K. Vine, and Jeffrey M. Trent 
ABSTRACT: Cytogenetic analysis was performed on short-term cultures of primary tumor samples from 
seven patients with posterior uveal melanoma. Informative data were obtained from four patients, all of 
whom had a near-diploid chromosomal number and clonal chromosomal alterations. Analysis of one 
patient's tumor revealed monosomy 3 as the only cytogenetically distinguishable aberration. Trisomies 
of chromosome 8 and i(8)(qlO) were detected in two other patients in combination with monosomy of chro- 
mosome 3. The fourth patient's karyotype displayed two different translocations. One translocation, 
der(6)t(6;8)(q12;q13.1), resulted in the over-representation of 8q13.1-~qter and a partial monosomy of 
6q12-*qter; the other translocation, der(9)t(6;9)(p12;p23), produced a partial trisomy of 6p12-~pter and 
a partial monosomy of 9p23~pter. These results support the view that the recurring pattern of chromosomal 
rearrangements in ocular melanoma is unique from that associated with cutaneous malignant melanoma. 
Furthermore, these results help confirm that chromosomes 3, 6, and 8 are nonrandomly altered in ocular 
melanoma. 
INTRODUCTION 
Posterior uveal melanoma (ciliary body and choroid) is the 
most common intraocuiar tumor of adult Caucasians. These 
tumors usually occur between the fourth and sixth decade 
of life and have a high incidence of metastasis [1, 2]. Unlike 
cutaneous melanoma, the severity of uveal melanoma does 
not correlate with patients' age [1]. In the world literature, 
14 families have been documented with at least two mem- 
bers having uveal melanoma. However, it has not yet been 
established that this is an inherited disorder [1, 3]. Although 
the etiology of uveal melanoma is unknown, ultraviolet radi- 
ation, chemical agents, viruses, and trauma have been im- 
plicated in its development [1, 2, 4]. 
Relatively few cases of cytogenetic analysis of uveal mela- 
noma have been reported to date. These studies have impli- 
cated monosomy 3, i(8)(ql0), trisomy 8, and alterations in 
6 as primary chromosomal alterations in the development 
of this tumor [5-9]. Recently, restriction fragment length poly- 
morphism analysis has confirmed the cytogenetic results in- 
dicating loss of heterozygosity on chromosome 3 and over- 
representation of 8q [10]. Loss of alleles on chromosome 2 
has also been reported [11], but there have been no reported 
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cytogenetic alterations involving this chromosome. In this 
report we provide complete cytogenetic information on four 
previously unpublished cases of ocular melanoma. 
MATERIALS AND METHODS 
Tumor samples were obtained from freshly enucleated eyes 
of patients with posterior uveal melanoma. Patients were not 
treated with radiation prior to enucleation. The clinical data 
of the patients and the histologic characterization of the 
tumors are summarized in Table 1. 
Immediately after enucleation the tumors were excised, 
mechanically minced, and treated with collagenase (2 ~g/ml) 
at 37°C for 15 minutes, then cultured in RPMI 1640 media 
supplemented with 10% fetal bovine serum, L-glutamine (2 
mM), and gentamicin (10 ng/ml). Incubation periods for the 
primary cultures varied from 3 to 10 days. To obtain mete- 
phases, the cells were treated with velban (2.5 ng/ml) for 
I hour, trypsinized, and subjected to 35 minutes of hypotonic 
(0.38% KC1) solution. Finally, the cells were gradually fixed 
with cold 3:1 methanol:acetic acid. Air-dried slides were 
banded by the GTG method [12]. Phytohemagglutinin-stimu- 
lated peripheral blood cultures were used to confirm consti- 
tutional karyotypes. 
Fluorescence in situ hybridization (FISH), as described 
by Pinkel [13], was used to help identify marker chromo- 
somes. Previously G-banded chromosomes were destained 
in a series of ethanol and formaldehyde/PBS washes [14]. 
They were then hybridized with whole chromosome compo- 
site painting probes furnished by Imagenetics (Naperville, IL). 
An average of 37 cells and nine karyotypes were exam- 
ined from each sample. Results presented conform to ISCN 
recommendations [15, 16]. 
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Table 1 His topa tho logy  of  pa t ien t  samples  
Tumor Maximum 
Patient thickness scleral dimension 
No. Age (yr) Sex (mm) (mm) Cell type 
Ciliary 
Mitosis Melanin body Infiltration of 
(#/40 hpf) a content involvement scleral lamellae 
M90-002 71 F 9.5 16 
M91-001 73 F 9.5 13 
M91-003 39 M 8.0 11 
M91-019 58 M 12.0 19 
M91-029 83 F 7.0 12 
M91--044 57 M 11.5 18 
M91-045 81 M 8.0 15 
Mixed 30 Moderate Yes Yes b 
Spindle 1 Moderate No No 
Mixed 7 Moderate Yes Yes 
Mixed 0 High Yes No 
Mixed 4 Moderate Yes Yes 
Epithelioid 0 High Yes No 
Epithelioid 11 Low Yes Yes 
° High-power field. 
b Extrascleral extension. 
RESULTS 
Pr imary  t u m o r  samples  were  ob ta ined  f rom seven pat ients  
w i t h  pos ter ior  uvea l  m e l a n o m a .  It was poss ib le  to obtain  
ana lyzable  me taphases  f rom four samples .  The  cytogenet ic  
resul ts  are s u m m a r i z e d  in Table 2. 
M90-002 
Figure  I i l lustrates the  s teml ine  karyotype  of case  M90-002:  
46,XX, - 3, + i(4)(p10),inv(8)(p21.3q11.2),i(8)(q10), + i(8)(q10), 
der(16)t(16;21)(q11;q11), - 17, - 21, + mar. Seventy-nine per  cent  
of the  cel ls  ana lyzed  demons t ra t ed  the  s teml ine  karyotype,  
whe rea s  7% had  n o n c l o n a l  rear rangements ,  and  14% were  
karyotypica l ly  normal .  M o n o s o m y  for c h r o m o s o m e  3 and 
i(8)(q10), resu l t ing  in a net  ga in  of 8q and a m o n o s o m y  of 
8p (Fig. 6), were  the most  c o m m o n  ch romosomal  aberrations 
observed in this case. Cytogenetic analysis of per ipheral  blood 
cel ls  f rom this pat ient  was also pe r fo rmed  and the  inv(8) was 
found  in all  ce l l s  examined ;  demons t ra t ing  this  to be a con- 
s t i tu t ional  al terat ion.  
M91-003 
Analys is  of the  t umor  sample  of this  pat ient  d isplayed no 
cy togent ica l ly  v is ib le  s t ructural  c h r o m o s o m a l  rearrange-  
ment ,  but  d id  reveal  m o n o s o m y  3 in 88% of the  cel ls  ex- 
amined .  
M91-029 
The  s teml ine  karyotype of case M91-029 demons t ra ted  
m o n o s o m y  3 and  an add i t iona l  c h r o m o s o m e  8, or  al terna- 
tively, an  i(8)(q10) as c lona l  c h r o m o s o m a l  al terat ions (Table 
2). A representat ive  karyotype of the  s temline:  46,XX, - 3, + 8 
was iden t i f ied  in 58% of the  cel ls  ana lyzed  (Fig. 2). In 8% 
of the  cei ls  there  was an i(8)(q10) ins tead of + 8, resu l t ing  
in a s igni f icant  over - representa t ion  of 8q (inset to Fig. 2; Ta- 
ble 2). The  15p + c h r o m o s o m e  iden t i f i ed  in this case was 
fur ther  ana lyzed  us ing  C-banding  and the  add i t iona l  mate- 
r ial  on  the  p a rm was iden t i f ied  as C-band pos i t ive  hetero- 
ch roma t in  (data not  shown).  The  15p + was also observed  
in karyotypes  f rom no rma l  cel ls  of the  pat ient ,  con f i rming  
that  this  was a cons t i tu t iona l  p o l y m o r p h i s m .  
Tab l e  2 S u m m a r y  of cy togene t i c  resul ts  
% of cells 
















46,XX, - 3, + i(4)(p10),inv(8)(p21.3q11.2),i(8)(q10), + i(8)(q10), 
der(16)t(16;21)(q11;q11), - 17, - 21, + mar[22] 
46,XX,inv(8)(p21.3q11.2}[4] 
NC[2] 
45,XY, - 3[29] 
46,XY[1] 
NC[3] 
46,XX, - 3, + 8131] 
46,XX, - 3, + i{8)(q10}[41 





Abbreviations: NC = non-clonal aberrations; ND = no analyzable metaphases obtained. 
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Figure 1 A representative karyotype from case M90-002. 46,XX,- 3, + i(4)(p10),inv(8)(p21.3q11.2),i(8)(q10), + i(8) 
(q10),der(16)t(16;21)(q11;q11),-17,- 21, + mar. The arrows indicate the marker chromosomes. 
M91-044 
The stemline karyotype of case M91-044 included two differ- 
ent translocations, resulting in partial trisomies for 6p and 
8q and partial monosomies for 9p and 6q, and a novel 
isodicentric chromosome I (Table 2; Fig. 3). Seventy-four per 
cent of the cells had the isodicentric chromosome, whereas 
the remaining 26% only had the two translocated chromo- 
somes. The der(6)t(6;8)(q12;q13.1) chromosome resulted in 
a partial trisomy of 8q13.1--~qter and a partial monosomy of 
6q12-~qter; the der(9)t(6;9)(p12;p23) chromosome yielded a 
partial trisomy of 6p12-*pter and a partial monosomy of 
9p23-'pter. The breakpoints of the nonreciprocal transloca- 
tions were identified following comparison of the translo- 
cared chromosomes to their respective normal chromosomes 
and confirmed by FISH (Fig. 4). 
The novel marker chromosome was shown to have 
markedly different contraction rates on either side of the chro- 
mosome (Fig. 5). Low-resolution banding made it difficult 
to characterize the marker chromosome (Fig. 5A); however, 
it was possible to discern that the marker was composed en- 
tirely of chromosome I using FISH (Fig. 5C). Comparison 
of high-resolution banding of the marker chromosome 1 to 
a normal chromosome 1 of equivalent length suggested that 
it was an isodicentric chromosome with the breakpoint lo- 
cated in band q23 (Fig. 5B). This unusual pattern of differen- 
tial contraction has been previously identified in other hu- 
man cancers [17]. 
In summary, monosomy 3 was the sole cytogenetic ab- 
normality present in one of the tumors analyzed in this study. 
Two cases had a trisomy for chromosome 8 or, alternatively, 
an i(8)(q10), along with monosomy 3 as the primary aberra- 
tions. Another case showed two novel translocations and a 
unique isodicentric chromosome. The der(6)t(6;8)(q12;q13.1) 
chromosome resulted in a partial trisomy and monosomy of 
8q13.1-~qter and 6q12~qter, respectively; the der(9)t(6;9) 
(p12;p23) chromosome gave rise to a partial trisomy of 
6p12-*pter and a partial monosomy of 9p23-*pter. The 
isodicentric marker chromosome, idic(1)(q23), exhibited a 
differential rate of contraction on either side of the break- 
point. Additionally, a subclone of this sample contained only 
the two translocations. 
DISCUSSION 
Informative cytogenetic analysis was performed on four of 
seven posterior uveal melanomas. As recognized in earlier 


























Figure 2 An example of a karyotype from case M91-029. 46,XX, - 3, + 8. The inset shows an example of two copies 
of normal chromosome 8 in addition to an i(8)(q10) present in a subpopulation of cells. 
studies, chromosomes 3, 6, and 8 are frequently altered in 
this malignancy [5-10]. Loss of an entire chromosome 3 was 
the sole visible cytogenetic aberration observed in case M91- 
003 (Table 2). This is the first reported incidence of mono- 
somy 3 as the only chromosomal abnormality in uveal mela- 
noma, further suggesting the importance of chromosome 3 
in the etiology of this disorder. Case M90-002 was shown to 
display monosomy of chromosome 3 and an i(8)(q10) as 
clonal aberrations. In addition, a combination of monosomy 
3 and trisomy 8, or alternatively, an i(8)(q10), were the major 
abnormalities observed in case M91-029. The final case, M91- 
044, illustrated two different translocations with chromo- 
somes 6 and 8 [der(9)t(6;9)(p12;p23) and der(6)t(6;8)(q12; 
q13.1)], which supports the importance of loci on 6 and 8q 
in the development or progression of this disorder. 
Including the four cases reported in this article, there are 
now a total of 26 cases of cytogenetically characterized 
posterior uveal melanomas published in the world literature 
[5-9]. Figure 6 presents a summary of the reported clonal 
chromosomal alterations, including a net loss of chromo- 
somes 3 and 6q and a net gain of 6p and 8q, observed in all 
published cases. To date, 50% (13/26) of cases are monosomic 
for chromosome 3; 31% (8/26) have aberrations producing 
a partial monosomy of 6q as well as an over-representation 
of 6p; 62 % (16/26) have multiple copies of 8q, and 23 % (6/26) 
of the cases revealed a loss of 8p. Over- and under-representa- 
t ion of loci on chromosomes 6 and 8 might be important in 
the mechanisms governing this malignancy. Many of the 
cases had varying combinations of the aberrations observed 
with these three chromosomes. The only ocular melanoma 
with a sole clonal alteration to date is from patient M91-003 
in this report, who exhibited a monosomy 3 as its only clonal 
chromosomal aberration. 
As described above, increases in the copy numbers of 6p 
and 8q and a partial reduction of loci on 6q are observed 
in posterior uveal melanomas (Fig. 6). Griffin et al. reported 
a case in which a translocation, t(6;21)(p10;q10), resulted in 
a trisomy of 6p. Sisley et al. reported a case in which a trisomy 
of 6p21-*pter resulted from a nonreciprocal translocation, 
t(6;11)(p21;p15), without any other abnormalities involving 
chromosomes 3 or 8. This is the smallest reported region of 
chromosome 6 observed to be over-represented in uveal mela- 
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Figure 3 An example of a karyotype from case M91-044. 46,XY, idic(1)(q23),der(6)t{6;8)(q12;q13.1),der(9)t(6;9)(p12;p23). 
The arrows indicate the marker chromosomes. 
noma (Fig. 6). The smallest  over-represented region of 8q, 
(8q21-'qter), and the smallest  under- represented region of 
6q, 6q22~qter, were reported by Prescher  et al. (1990) (Fig. 
6). These aforementioned studies, in addi t ion  to the data ob- 
ta ined from case M91-044, provide further evidence that 
Figure 4 Examples of non reciprocal translocation chromosomes 
from case M91-044. A) The t(6;8)(q12;q13.1) chromosome is compared 
to normal chromosomes 6 and 8. B) Comparison of t(6;9)(p12;p23) 
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regions 6p21-"pter, 6q22~qter, and 8q21-'qter are potentially 
important  in this malignancy. A partial  monosomy of 9p was 
observed only in case M91-044, suggesting that it was poten- 
t ia l ly important  in the development  of uveal melanoma in 
this patient. Further cytogenetic and molecular analyses need 
to be performed to investigate the possible  involvement of 
loci on 9p in posterior uveal melanoma.  
Al though abnormali t ies  of chromosome 1 are the most 
frequent alterations in cutaneous mal ignant  melanoma [18], 
there are surpr is ingly  few reported for uveal melanoma.  No 
consistent net gain or loss of any port ion of chromosome 1 
has been observed. The most unusual  alteration of chromo- 
some 1 reported to date was seen in our case M91-044, in 
which  there was an isodicentric chromosome 1. We observed 
a differential banding pattern on either side of the breakpoint 
(Fig. 5), and it is possible  that this t ranslocat ion might have 
been responsible  for the abnormal pattern of chromatid con- 
densat ion.  Similar  differential  condensat ion  has been 
reported previously  [17], a l though the mechanism respon- 
sible for this change has not been determined.  
In addi t ion to chromosome 1, nonrandom rearrangements 
of chromosomes 6, 7, and 11 are frequently associated with  
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Figure 5 Idic(1)(q23) from case M91-044. A) Examples of low- 
resolution G-banding isodicentric chromosome I from three differ- 
ent cells. B) Comparison of high-resolution G-banded isodicentric 
chromosome 1 with a normal chromosome 1. C) The normal and 
isodicentric chromosome I were analyzed sequentially by G-banding 
followed by FISH. The chromosomes were identified with bi- 
otinylated chromosome painting probes. 
cu taneous  m e l a n o m a .  In  contrast ,  c h r o m o s o m e  3, 6, and 8 
are the  most  cons is ten t ly  a l tered in  poster ior  uvea l  mela-  
noma.  C h r o m o s o m e  6 is the  on ly  c o m m o n  c h r o m o s o m e  that  
is rear ranged  in these  two types  of m e l a n o m a .  A l t h o u g h  6q 
is most  f requen t ly  involved  w i t h  cu taneous  m e l a n o m a  [18], 
6p and 6q are a l tered in uvea l  m e l a n o m a .  The  dis t inct  
cy togenet ic  character is t ics  of cu taneous  and uvea l  mela-  
nomas  indicate  that  d i f ferent  loci  and,  therefore ,  defects in 
different  genes  are l ikely to be involved  in the  genes is  and  
p rogress ion  of these  cancers.  
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Figu re  6 Summation of the recurring aberrations involving chromosomes 3, 6, and 8 from 26 reported cases of 
uveal melanoma [5-9]. This representation is based on the combined clonal numerical and structural abnormalities 
reported. 
